Evidence map›Paper›PMID 25810759›Full record

ArticleInfectious agents and cancer2015

IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes.

Adriana C Vidal, David Skaar, Rachel Maguire, Seyram Dodor, Laura W Musselwhite, John A Bartlett, Olola Oneko, Joseph Obure, Pendo Mlay, Susan K Murphy and 1 more

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Adriana C VidalDepartment of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, CA USA.
David SkaarDepartment of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC USA.
Rachel MaguireDepartment of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC USA.
Seyram DodorSchool of Science and Mathematics, North Carolina State University, Raleigh, NC USA.
Laura W MusselwhiteGlobal Health Program, Duke University Medical Center, Durham, NC USA.
John A BartlettDepartment of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC USA.
Olola OnekoKilimanjaro Christian Medical Center, Moshi, Tanzania.
Joseph ObureKilimanjaro Christian Medical Center, Moshi, Tanzania.
Pendo MlayKilimanjaro Christian Medical Center, Moshi, Tanzania.
Susan K MurphyDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University School of Medicine, Durham, NC USA.
Cathrine HoyoDepartment of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC USA.
North Carolina State University · USDuke University · USKilimanjaro Christian Medical Centre · TZCedars-Sinai Medical Center · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI DOLIN, RAPHAEL · 2005 to 2005
$14.9M
Disparities in cervical cancer precursors and deregulation of imprinted genesR01CA142983 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI HOYO, CATHRINE, MURPHY, SUSAN KAY · 2010 to 2014
$3.0M
AIDS International Training and Research ProgramD43TW006732 · FIC · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2004 to 2012
$2.7M
Developing Research Capacity in Africa for Studies on HIV-Associated MalignanciesD43CA153722 · NCI · DUKE UNIVERSITY · PI BARTLETT, JOHN A · 2010 to 2013
$1.6M
FIC NIH HHS D43 TW006732NCI NIH HHS D43 CA153722NCI NIH HHS R01 CA142983NIAID NIH HHS P30 AI064518NIAID NIH HHS U01 AI067854
6 · The paper itself

Abstract

backgroundDespite comparable screening rates for precancerous lesions, higher incidence and mortality related to cervical cancer in minority women persists. Recent evidence suggests that minority women with precancerous cervical lesions harbor a wider range of human papillomavirus (HPV) genotypes, many of these distinct from HPV16/18, those most commonly found in Caucasian women. The goal of the analysis was to determine if inflammatory cytokines and chemokines varied by HPV 16/18 versus other genotypes in cervical cancer tissues from Tanzanian women.

methodsHPV genotypes and concentrations of chemokines and cytokines were measured from homogenized fresh tumor tissue of thirty-one women with invasive cervical cancer (ICC). Risk factors for cervical cancer including age, parity, hormonal contraceptive use and cigarette smoking were obtained by questionnaire. Generalized linear models were used to evaluate differences between chemokines/cytokine levels in women infected with HPV16/18 and those infected with other HPV genotypes.

resultsAfter adjusting for age, parity and hormonal contraceptives, IL-17 was found significantly more frequently in invasive cervical cancer samples of women infected with HPV16/18 compared to women infected with other HPV genotypes (p = 0.033). In contrast, higher levels for granular macrophage colony-stimulating factor (p = 0.004), IL-10 (p = 0.037), and IL-15 (p = 0.041) were found in ICC tissues of women infected with genotypes other than HPV16/18 when compared to those of women infected with HPV16/18.

conclusionsWhile the small sample size limits inference, our data suggest that infection with different HPV genotypes is associated with distinct pro-inflammatory cytokine expression profiles; whether this explains some of the racial differences observed in cervical cancer is still unclear. Future studies are needed to confirm these findings.

Indexed as

Case-onlyCytokinesDisparitiesHPV infectionInvasive cervical cancerRace

Identifiers

PMID25810759
PMCPMC4373111
OpenAlexW2135676871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.